1
|
Kalkut G: Antiretroviral therapy: an
update for the non-AIDS specialist. Curr Opin Oncol. 17:479–484.
2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Borrás-Blasco J, Navarro-Ruiz A, Borrás C
and Casterá E: Adverse cutaneous reactions associated with the
newest antiretroviral drugs in patients with human immunodeficiency
virus infection. J Antimicrob Chemother. 62:879–888.
2008.PubMed/NCBI
|
3
|
Borrás-Blasco J, Belda A, Rosique-Robles
JD, Casterá MD and Abad FJ: Burning mouth syndrome due to efavirenz
therapy. Ann Pharmacother. 40:1471–1472. 2006.PubMed/NCBI
|
4
|
Casariego Z and Ben G: Oral manifestations
of HIV infection in Argentina: a study of 1889 cases. Med Oral.
3:271–276. 1998.
|
5
|
Porche DJ: Efavirenz. J Assoc Nurses AIDS
Care. 11:95–98. 2000. View Article : Google Scholar
|
6
|
Dona C, Soriano V, Barreiro P,
Jiménez-Náchera I and González-Lahoz J: Toxicity associated to
efavirenz in HIV-infected persons enrolled in an expanded access
program. Med Clin. 115:337–338. 2000.PubMed/NCBI
|
7
|
Yoshimoto E, Konishi M, Takahashi K,
Murakawa K, Maeda K, Mikasa K and Yamashina Y: The first case of
efavirenz-induced photosensitivity in a Japanese patient with HIV
infection. Intern Med. 43:630–631. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Behrens GM, Stoll M and Schmidt RE:
Pulmonary hypersensitivity reaction induced by efavirenz. Lancet.
357:1503–1504. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
Angel-Moreno-Maroto A, Suárez-Castellano
L, Hernández-Cabrera M and Pérez-Arellano JL: Severe
efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute
renal failure. J Infect. 52:e39–e40. 2006. View Article : Google Scholar
|
10
|
Punwani K, Suedkamp S, Nguyen D and Song
JC: Update on the CNS adverse effects of Sustiva (efavirenz). AIDS
Alert. 22:32–34. 2007.PubMed/NCBI
|
11
|
Brück S, Witte S, Brust J, Schuster D,
Mosthaf F, Procaccianti M, Rump JA, Klinker H, Petzold D and
Hartmann M: Hepatotoxicity in patients prescribed efavirenz or
nevirapine. Eur J Med Res. 13:343–348. 2008.
|
12
|
Bertrand-Vallery V, Boilan E, Ninane N,
Demazy C, Friguet B, Toussaint O, Poumay Y and Debacq-Chainiaux F:
Repeated exposures to UVB induce differentiation rather than
senescence of human keratinocytes lacking p16(INK-4A).
Biogerontology. 11:167–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Agger K, Cloos PA, Rudkjaer L, Williams K,
Andersen G, Christensen J and Helin K: The H3K27me3 demethylase
JMJD3 contributes to the activation of the INK4A-ARF locus in
response to oncogene- and stress-induced senescence. Genes Dev.
23:1171–1176. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Young AR and Narita M, Ferreira M,
Kirschner K, Sadaie M, Darot JF, Tavaré S, Arakawa S, Shimizu S,
Watt FM and Narita M: Autophagy mediates the mitotic senescence
transition. Genes Dev. 23:798–803. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Klionsky DJ: Autophagy: from phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Liang C and Jung JU: Autophagy genes as
tumor suppressors. Curr Opin Cell Biol. 22:226–233. 2010.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wu YT, Tan HL, Shui G, Bauvy C, Huang Q,
Wenk MR, Ong CN, Codogno P and Shen HM: Dual role of
3-methyladenine in modulation of autophagy via different temporal
patterns of inhibition on class I and III phosphoinositide
3-kinase. J Biol Chem. 285:10850–10861. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kang MK, Bibb C, Baluda MA, Rey O and Park
NH: In vitro replication and differentiation of normal human oral
keratinocytes. Exp Cell Res. 258:288–297. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Boukamp P, Petrussevska RT, Breitkreutz D,
Hornung J, Markham A and Fusenig NE: Normal keratinization in a
spontaneously immortalized aneuploid human keratinocyte cell line.
J Cell Biol. 106:761–771. 1988. View Article : Google Scholar : PubMed/NCBI
|
21
|
Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu
JY, Weinberg RA, Louis DN, Li FP and Rheinwald JG: Human
keratinocytes that express hTERT and also bypass a
p16(INK4a)-enforced mechanism that limits life span become immortal
yet retain normal growth and differentiation characteristics. Mol
Cell Biol. 20:1436–1447. 2000. View Article : Google Scholar
|
22
|
Dongari-Bagtzoglou A and Kashleva H:
Development of a highly reproducible three-dimensional organotypic
model of the oral mucosa. Nat Protoc. 1:2012–2018. 2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH,
Dimri GP, Christensen R, Han T and Park NH: Elevated Bmi-1
expression is associated with dysplastic cell transformation during
oral carcinogenesis and is required for cancer cell replication and
survival. Br J Cancer. 96:126–133. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kim Y, McBride J, Zhang R, Zhou X and Wong
DT: p12 (CDK2-AP1) mediates DNA damage responses induced by
cisplatin. Oncogene. 24:407–418. 2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kurokawa M and Kornbluth S: Caspases and
kinases in a death grip. Cell. 138:838–854. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Gong D and Ferrell J Jr: The roles of
cyclin A2, B1, and B2 in early and late mitotic events. Mol Biol
Cell. 21:3149–3161. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Bursch W, Ellinger A, Gerner C, Fröhwein U
and Schulte-Hermann R: Programmed cell death (PCD). Apoptosis,
autophagic PCD, or others? Ann NY Acad Sci. 926:1–12. 2000.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Tasdemir E, Maiuri MC, Galluzzi L, Vitale
I, Djavaheri-Mergny M, D'Amelio M, Criollo A, Morselli E, Zhu C,
Harper F, Nannmark U, Samara C, Pinton P, Vicencio JM, Carnuccio R,
Moll UM, Madeo F, Paterlini-Brechot P, Rizzuto R, Szabadkai G,
Pierron G, Blomgren K, Tavernarakis N, Codogno P, Cecconi F and
Kroemer G: Regulation of autophagy by cytoplasmic p53. Nat Cell
Biol. 10:676–687. 2008. View
Article : Google Scholar : PubMed/NCBI
|
29
|
Dong Q, Oh JE, Chen W, Kim R, Kim RH, Shin
KH, McBride WH, Park NH and Kang MK: Radioprotective effects of
Bmi-1 involve epigenetic silencing of oxidase genes and enhanced
DNA repair in normal human keratinocytes. J Invest Dermatol.
131:1216–1225. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liang J, Shao SH, Xu ZX, Hennessy B, Ding
Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL,
Slingerland JM and Mills GB: The energy sensing LKB1-AMPK pathway
regulates p27(kip1) phosphorylation mediating the decision to enter
autophagy or apoptosis. Nat Cell Biol. 9:218–224. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Pattingre S, Tassa A, Qu X, Garuti R,
Liang XH, Liang XH, Mizushima N, Packer M, Schneider MD and Levine
B: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent
autophagy. Cell. 122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Kang MK, Guo W and Park NH: Replicative
senescence of normal human oral keratinocytes is associated with
the loss of telomerase activity without shortening of telomeres.
Cell Growth Differ. 9:85–95. 1998.PubMed/NCBI
|
33
|
Kang MK, Kameta A, Shin KH, Baluda MA and
Park NH: Senescence occurs with hTERT repression and limited
telomere shortening in human oral keratinocytes cultured with
feeder cells. J Cell Physiol. 199:364–370. 2004. View Article : Google Scholar : PubMed/NCBI
|
34
|
Yugawa T, Narisawa-Saito M, Yoshimatsu Y,
Haga K, Ohno S, Egawa N, Fujita M and Kiyono T: DeltaNp63alpha
repression of the Notch1 gene supports the proliferative capacity
of normal human keratinocytes and cervical cancer cells. Cancer
Res. 70:4034–4044. 2010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Futreal PA, Söderkvist P, Marks JR,
Iglehart JD, Cochran C, Barrett JC and Wiseman RW: Detection of
frequent allelic loss on proximal chromosome 17q in sporadic breast
carcinoma using microsatellite length polymorphisms. Cancer Res.
52:2624–2627. 1992.
|
36
|
Cliby W, Ritland S, Hartmann L, Dodson M,
Halling KC, Keeney G, Podratz KC and Jenkins RB: Human epithelial
ovarian cancer allelotype. Cancer Res. 53(Suppl 10): S2393–S2398.
1993.
|
37
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y,
Cattoretti G and Levine B: Promotion of tumorigenesis by
heterozygous disruption of the beclin 1 autophagy gene. J Clin
Invest. 112:1809–1820. 2003. View
Article : Google Scholar : PubMed/NCBI
|
39
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, Nelson
DA, Jin S and White E: Autophagy promotes tumor cell survival and
restricts necrosis, inflammation, and tumorigenesis. Cancer Cell.
10:51–64. 2006. View Article : Google Scholar : PubMed/NCBI
|
40
|
Carew JS, Nawrocki ST, Kahue CN, Zhang H,
Yang C, Chung L, Houghton JA, Huang P, Giles FJ and Cleveland JL:
Targeting autophagy augments the anticancer activity of the histone
deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug
resistance. Blood. 110:313–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
41
|
Ståhle L, Moberg L, Svensson JO and
Sönnerborg A: Efavirenz plasma concentrations in HIV-infected
patients: inter- and intraindividual variability and clinical
effects. Ther Drug Monit. 26:267–270. 2004.PubMed/NCBI
|
42
|
Marzolini C, Telenti A, Decosterd LA,
Greub G, Biollaz J and Buclin T: Efavirenz plasma levels can
predict treatment failure and central nervous sytem side effects in
HIV-1-infected patients. AIDS. 15:71–75. 2001. View Article : Google Scholar : PubMed/NCBI
|